Literature DB >> 28881428

Densification of Type I Collagen Matrices as a Model for Cardiac Fibrosis.

Logan J Worke1, Jeanne E Barthold2, Benjamin Seelbinder2, Tyler Novak1, Russell P Main1,3, Sherry L Harbin1,3, Corey P Neu1,2.   

Abstract

Cardiac fibrosis is a disease state characterized by excessive collagenous matrix accumulation within the myocardium that can lead to ventricular dilation and systolic failure. Current treatment options are severely lacking due in part to the poor understanding of the complexity of molecular pathways involved in cardiac fibrosis. To close this gap, in vitro model systems that recapitulate the defining features of the fibrotic cellular environment are in need. Type I collagen, a major cardiac extracellular matrix protein and the defining component of fibrotic depositions, is an attractive choice for a fibrosis model, but demonstrates poor mechanical strength due to solubility limits. However, plastic compression of collagen matrices is shown to significantly increase its mechanical properties. Here, confined compression of oligomeric, type I collagen matrices is utilized to resemble defining hallmarks seen in fibrotic tissue such as increased collagen content, fibril thickness, and bulk compressive modulus. Cardiomyocytes seeded on compressed matrices show a strong beating abrogation as observed in cardiac fibrosis. Gene expression analysis of selected fibrosis markers indicates fibrotic activation and cardiomyocyte maturation with regard to the existing literature. With these results, a promising first step toward a facile heart-on-chip model is presented to study cardiac fibrosis.
© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  density; heart-on-chip; oligomeric collagen; plastic compression; tissue engineering

Mesh:

Substances:

Year:  2017        PMID: 28881428      PMCID: PMC5844700          DOI: 10.1002/adhm.201700114

Source DB:  PubMed          Journal:  Adv Healthc Mater        ISSN: 2192-2640            Impact factor:   9.933


  74 in total

Review 1.  Temporal and spatial expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases following myocardial infarction.

Authors:  Merry L Lindsey; Rogelio Zamilpa
Journal:  Cardiovasc Ther       Date:  2010-07-14       Impact factor: 3.023

2.  The basic helix-loop-helix transcription factor scleraxis regulates fibroblast collagen synthesis.

Authors:  Leon Espira; Lise Lamoureux; Stephen C Jones; Robert D Gerard; Ian M C Dixon; Michael P Czubryt
Journal:  J Mol Cell Cardiol       Date:  2009-04-10       Impact factor: 5.000

3.  Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease.

Authors:  C G Brilla; R C Funck; H Rupp
Journal:  Circulation       Date:  2000-09-19       Impact factor: 29.690

4.  Protective effects of triptolide on TLR4 mediated autoimmune and inflammatory response induced myocardial fibrosis in diabetic cardiomyopathy.

Authors:  Xin Guo; Mei Xue; Chun-Jun Li; Wei Yang; Shan-Shan Wang; Ze-Jun Ma; Xiao-Na Zhang; Xiao-Yu Wang; Ran Zhao; Bao-Cheng Chang; Li-Ming Chen
Journal:  J Ethnopharmacol       Date:  2016-08-21       Impact factor: 4.360

5.  Mechanical coupling between myofibroblasts and cardiomyocytes slows electric conduction in fibrotic cell monolayers.

Authors:  Susan A Thompson; Craig R Copeland; Daniel H Reich; Leslie Tung
Journal:  Circulation       Date:  2011-05-02       Impact factor: 29.690

6.  Embryonic cardiomyocytes beat best on a matrix with heart-like elasticity: scar-like rigidity inhibits beating.

Authors:  Adam J Engler; Christine Carag-Krieger; Colin P Johnson; Matthew Raab; Hsin-Yao Tang; David W Speicher; Joseph W Sanger; Jean M Sanger; Dennis E Discher
Journal:  J Cell Sci       Date:  2008-10-28       Impact factor: 5.285

Review 7.  Heart failure: when form fails to follow function.

Authors:  Arnold M Katz; Ellis L Rolett
Journal:  Eur Heart J       Date:  2015-10-24       Impact factor: 29.983

8.  TIMP-3 deficiency accelerates cardiac remodeling after myocardial infarction.

Authors:  Hai Tian; Massimo Cimini; Paul W M Fedak; Svetlana Altamentova; Shafie Fazel; Ming-Li Huang; Richard D Weisel; Ren-Ke Li
Journal:  J Mol Cell Cardiol       Date:  2007-09-14       Impact factor: 5.000

9.  Role of transiently altered sarcolemmal membrane permeability and basic fibroblast growth factor release in the hypertrophic response of adult rat ventricular myocytes to increased mechanical activity in vitro.

Authors:  D Kaye; D Pimental; S Prasad; T Mäki; H J Berger; P L McNeil; T W Smith; R A Kelly
Journal:  J Clin Invest       Date:  1996-01-15       Impact factor: 14.808

Review 10.  A systematic review of fetal genes as biomarkers of cardiac hypertrophy in rodent models of diabetes.

Authors:  Emily J Cox; Susan A Marsh
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240

View more
  2 in total

1.  Nuclear deformation guides chromatin reorganization in cardiac development and disease.

Authors:  Benjamin Seelbinder; Soham Ghosh; Stephanie E Schneider; Adrienne K Scott; Alycia G Berman; Craig J Goergen; Kenneth B Margulies; Kenneth C Bedi; Eduard Casas; Alison R Swearingen; Justin Brumbaugh; Sarah Calve; Corey P Neu
Journal:  Nat Biomed Eng       Date:  2021-12-02       Impact factor: 29.234

2.  Cardioprotective Effects of Dietary Flaxseed Post-Infarction Are Associated with Changes in MicroRNA Expression.

Authors:  Mihir Parikh; Branislav Kura; Kimberley A O'Hara; Elena Dibrov; Thomas Netticadan; Jan Slezak; Grant N Pierce
Journal:  Biomolecules       Date:  2020-09-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.